Real-World Management of Thyroid Cancer with TRK Inhibitors

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD

Dr Ezra Cohen of UC San Diego, La Jolla, CA, and Dr Mary Fidler of Rush University Medical Center, Chicago, IL, recount their clinical experiences and the journeys of patients treated with TRK inhibitors for thyroid cancer.

Related Videos

January 20, 2016

Defining Cancer Stem Cells

Dr Gerson provides an overview of cancer stem cells.

January 10, 2019

Is Immunotherapy Appropriate Here?

Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.